<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01840098</url>
  </required_header>
  <id_info>
    <org_study_id>1-10-72-63-13</org_study_id>
    <nct_id>NCT01840098</nct_id>
  </id_info>
  <brief_title>Leucine and Beta-hydroxy-beta-methylbutyrate (HMB) as Anabolic Nutrients After 36 Hours of Fasting</brief_title>
  <official_title>Leucine and Beta-hydroxy-beta-methylbutyrate (HMB) as Anabolic Nutrients After 36 Hours of Fasting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate metabolic effects of 3 different nutritional
      compounds.

      Fasting (36 hours) creates a catabolic state that is comparable with the catabolic state seen
      in acute illness.

      This study is a randomized, placebo cross-over study investigating 8 healthy men on 4
      separated days (at least 3 weeks between trials).

        -  High leucine content drink

        -  Low leucine content drink

        -  Low leucine content drink + HMB

        -  Carbohydrate (isocaloric)

      The investigators hypothesize that these nutritional supplements may counteract catabolic
      processes in different ways and degrees.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Protein metabolism after 36 hours fasting receiving different nutritional supplements.</measure>
    <time_frame>3 control period followed by 4 hours of nutritional drink intake</time_frame>
    <description>Protein metabolism is measured with amino acid tracer techniques comparing marked amino acids from blood samples. Muscle and fat biopsies are obtained for signaling analysis. Indirect calorimetry measurements are used to compare metabolism in the control period and during the intervention.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Fasting</condition>
  <condition>Metabolism</condition>
  <condition>Nutrition Support</condition>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Isocaloric carbohydrate drink</description>
  </arm_group>
  <arm_group>
    <arm_group_label>low leucine content drink</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A soy protein drink</description>
  </arm_group>
  <arm_group>
    <arm_group_label>high content of leucine drink</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A whey protein drink</description>
  </arm_group>
  <arm_group>
    <arm_group_label>low leucine content + HMB drink</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Soy protein drink added HMB</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>low leucine content drink</intervention_name>
    <arm_group_label>low leucine content drink</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>high leucine content drink</intervention_name>
    <arm_group_label>high content of leucine drink</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>low leucine + HMB drink</intervention_name>
    <arm_group_label>low leucine content + HMB drink</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control/carbohydrate</intervention_name>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>36 hour fasting</intervention_name>
    <arm_group_label>control</arm_group_label>
    <arm_group_label>low leucine content drink</arm_group_label>
    <arm_group_label>high content of leucine drink</arm_group_label>
    <arm_group_label>low leucine content + HMB drink</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male gender

          -  20&lt;BMI&lt;30

          -  Age &gt; 20 years old

          -  Written consent before starting the study

        Exclusion Criteria:

          -  Allergy for soya products ore egg

          -  Diabetes

          -  Epilepsy

          -  Infection

          -  Immune defects

          -  Heart disease

          -  Dysregulated hypertension

          -  Participating in other trials using radioactive tracers or x-rays the last year.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Internal Medicine and Endocrinology, Aarhus Universitetshospital</name>
      <address>
        <city>Aarhus C</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 17, 2013</study_first_submitted>
  <study_first_submitted_qc>April 22, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 25, 2013</study_first_posted>
  <last_update_submitted>November 4, 2014</last_update_submitted>
  <last_update_submitted_qc>November 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 5, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Aarhus</investigator_affiliation>
    <investigator_full_name>Nikolaj Fibiger Rittig</investigator_full_name>
    <investigator_title>MD (medical graduate) and Ph.d.-student</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

